China Exclusions Extended Through May 31, 2024
The United States Trade Representative (USTR) is further extending Section 301 China product exclusions through May 31, 2024. The exclusions were previously scheduled to expire December 31, 2023. The covered exclusions include 352 previously reinstated exclusions and 77 COVID-related exclusions.According to[...]
read moreLast Batch of China Product Exclusions Extended Again– 9903.88.67 & 9903.88.68
The USTR extended 429 Section 301 China product exclusions through Dec 31, 2023.[...]
read more77 COVID-Related Section 301 Exclusions Extended Through Sept 30
The USTR postponed the expiration of 81 exclusions until May 31 and further renewed all but 4 exclusions through Sept 30. [...]
read moreCOVID-Related Medical Product Exclusions Extended Until May 15th
Eighty-one COVID medical related product exclusions extended pending USTR comment period.[...]
read moreSection 301 Exclusions Extended Again – 9903.88.67
352 product exclusions are extended for an additional nine months.[...]
read more301 China COVID Exclusions Extended – 9903.88.66
Eighty-one COVID medical-care product exclusions now expire on February 28, 2023.[...]
read moreSection 301 Conforming and Technical Amendments Issued
On October 14, 2022, the U.S. Trade Representative issued two notices, 87 FR 62485 and 87 FR 62486 detailing conforming and technical amendments to Section 301 China exclusions. The amendments reflect two changes made to exclusion descriptions (Exclusion 50, 51)[...]
read moreSection 301 China: 4-Year Review Next Steps
On October 12th, 2022, the U.S. Trade Representative (USTR) announced the next steps in the Section 301 China 4-Year Review Process. The public will have the opportunity to submit comments online about the effectiveness of the Section 301 China List[...]
read more301 China Tariffs Continue With No Change
On September 8, 2022, the U.S. Trade Representative (USTR) released an official notice that the Section 301 China tariffs will continue. The notice follows the first step in the statutory four-year review process, where the USTR provided the opportunity for representatives[...]
read more